Table 2.
Wk-0 | Wk-8 | Wk-16 | Wk-21 | |
---|---|---|---|---|
Control (n = 12) | 5/12 (42%) | 6/12 (50%) | 8/12 (67%) | 9/12 (75%) |
Treated (n = 12) | 6/12 (50%) | 2/12 (17%) | 0/12 (0%)** | 6/12 (50%) |
***P < 0.001 compared between-groups at each week using Fisher’s exact test
Wk-0 | Wk-8 | Wk-16 | Wk-21 | |
---|---|---|---|---|
Control (n = 12) | 5/12 (42%) | 6/12 (50%) | 8/12 (67%) | 9/12 (75%) |
Treated (n = 12) | 6/12 (50%) | 2/12 (17%) | 0/12 (0%)** | 6/12 (50%) |
***P < 0.001 compared between-groups at each week using Fisher’s exact test